Aankondiging • Jun 30
S Crypto Energy Inc. to Report Q1, 2027 Results on Aug 14, 2026 S Crypto Energy Inc. announced that they will report Q1, 2027 results on Aug 14, 2026 Aankondiging • May 15
S Crypto Energy Inc., Annual General Meeting, Jun 29, 2026 S Crypto Energy Inc., Annual General Meeting, Jun 29, 2026. New Risk • May 15
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: JP¥14.2b (US$89.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (JP¥14.2b market cap, or US$89.6m). Aankondiging • May 09
S Crypto Energy Inc. to Report Fiscal Year 2026 Results on May 14, 2026 S Crypto Energy Inc. announced that they will report fiscal year 2026 results on May 14, 2026 New Risk • Apr 06
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: JP¥15.4b (US$96.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (JP¥15.4b market cap, or US$96.7m). New Risk • Jan 03
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 24% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (21% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.4% net profit margin). Shareholders have been diluted in the past year (24% increase in shares outstanding). Aankondiging • Dec 16
S Science Company, Ltd. to Report Q3, 2026 Results on Feb 13, 2026 S Science Company, Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026 New Risk • Nov 15
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Share price has been highly volatile over the past 3 months (24% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (4.4% net profit margin). Aankondiging • Sep 27
S Science Company, Ltd. to Report Q2, 2026 Results on Nov 14, 2025 S Science Company, Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025 Aankondiging • Aug 20
S Science Company, Ltd. announced that it expects to receive ¥40.842 million in funding from Long Corridor Asset Management Limited, Lighthouse Investment Partners, LLC, Blackstone Alternative Asset Management L.P., Kay Leo Brothers Limited and another investor S Science Company, Ltd. announced a private placement to issue 334,500 series 8 stock acquisition rights at an issue price of ¥72 for gross proceeds of ¥24,084,000 and 220,500 series 9 stock acquisition rights at an issue price of ¥76 for gross proceeds of ¥16,758,000 for aggregate proceeds of ¥40,842,000 on August 18, 2025. The transaction includes participation from new investor, Long Corridor Alpha Opportunities Master Fund, a fund managed by Long Corridor Asset Management Limited for 234,150 stock acquisition rights, LMA SPC - MAP 246 Segregated Portfolio, a fund managed by Lighthouse Investment Partners, LLC for 33,450 stock acquisition rights, Bemap Master Fund Ltd., a fund managed by Blackstone Alternative Asset Management L.P. for 66,900 stock acquisition rights in series 8 stock acquisition rights offering and from Kay Leo Brothers Limited for 175,000 stock acquisition rights and Yuta Misaki for 45,500 stock acquisition rights in series 9 stock acquisition rights offering. The potential shares from issuance of series 8 stock acquisition rights will be 33,450,000 and from issuance of series 9 stock acquisition rights will be 22,050,000. The initial exercise price of stock acquisition right will be ¥122 for an exercise period from September 5, 2025 to September 4, 2028. The transaction will happen through third party allocation. The issue date will be September 4, 2025. The transaction has been approved at board of director meeting of the company. Aankondiging • Jun 20
S Science Company, Ltd. to Report Q1, 2026 Results on Aug 14, 2025 S Science Company, Ltd. announced that they will report Q1, 2026 results on Aug 14, 2025 New Risk • Jun 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (37% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Profit margins are more than 30% lower than last year (4.4% net profit margin). Market cap is less than US$100m (JP¥11.0b market cap, or US$76.9m). Aankondiging • May 15
S Science Company, Ltd., Annual General Meeting, Jun 27, 2025 S Science Company, Ltd., Annual General Meeting, Jun 27, 2025. Aankondiging • Mar 25
S Science Company, Ltd. to Report Fiscal Year 2025 Results on May 14, 2025 S Science Company, Ltd. announced that they will report fiscal year 2025 results on May 14, 2025 New Risk • Mar 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.4% net profit margin). Market cap is less than US$100m (JP¥4.25b market cap, or US$28.5m). Valuation Update With 7 Day Price Move • Mar 13
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to JP¥28.00, the stock trades at a trailing P/E ratio of 72.1x. Average trailing P/E is 11x in the Metals and Mining industry in Japan. Total loss to shareholders of 24% over the past three years. Aankondiging • Dec 20
S Science Company, Ltd. to Report Q3, 2025 Results on Feb 13, 2025 S Science Company, Ltd. announced that they will report Q3, 2025 results on Feb 13, 2025 New Risk • Nov 21
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 42% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.9% average weekly change). High level of non-cash earnings (42% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.4% net profit margin). Market cap is less than US$100m (JP¥3.12b market cap, or US$20.2m). Aankondiging • Sep 21
S Science Company, Ltd. to Report Q2, 2025 Results on Nov 13, 2024 S Science Company, Ltd. announced that they will report Q2, 2025 results on Nov 13, 2024 Valuation Update With 7 Day Price Move • Jul 31
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to JP¥27.00, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 10x in the Metals and Mining industry in Japan. Total loss to shareholders of 29% over the past three years. Valuation Update With 7 Day Price Move • Jul 05
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to JP¥27.00, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 11x in the Metals and Mining industry in Japan. Total loss to shareholders of 27% over the past three years. Aankondiging • Jun 22
S Science Company, Ltd. to Report Q1, 2025 Results on Aug 13, 2024 S Science Company, Ltd. announced that they will report Q1, 2025 results on Aug 13, 2024 Aankondiging • May 31
Life Intelligent Enterprise Holdings Co.,Ltd. (TSE:5856) agreed to acquire Nagomi Sekkei Co., Ltd. from S Science Company, Ltd. (TSE:5721). Life Intelligent Enterprise Holdings Co.,Ltd. (TSE:5856) agreed to acquire Nagomi Sekkei Co., Ltd. from S Science Company, Ltd. (TSE:5721) on May 30, 2024. As part of the transaction, Life Intelligent will acquire 3,021 shares of Nagomi Sekkei. The parties are scheduled to enter into an agreement on July 1, 2024 or later after approval at the Shareholders Meeting. The transaction is conditional upon shareholder approval of S Science. The transaction is expected to close on July 1, 2024 or later after approval at the Shareholders Meeting. Reported Earnings • May 17
Full year 2024 earnings released: EPS: JP¥3.01 (vs JP¥0.74 loss in FY 2023) Full year 2024 results: EPS: JP¥3.01 (up from JP¥0.74 loss in FY 2023). Revenue: JP¥1.54b (up 14% from FY 2023). Net income: JP¥426.0m (up JP¥531.0m from FY 2023). Profit margin: 28% (up from net loss in FY 2023). Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Aankondiging • May 16
S Science Company, Ltd., Annual General Meeting, Jun 27, 2024 S Science Company, Ltd., Annual General Meeting, Jun 27, 2024. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to JP¥26.00, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 9x in the Metals and Mining industry in Japan. Total loss to shareholders of 40% over the past three years. Aankondiging • Mar 02
S Science Company, Ltd. to Report Fiscal Year 2024 Results on May 13, 2024 S Science Company, Ltd. announced that they will report fiscal year 2024 results on May 13, 2024 Reported Earnings • Feb 15
Third quarter 2024 earnings released: EPS: JP¥1.04 (vs JP¥0.21 loss in 3Q 2023) Third quarter 2024 results: EPS: JP¥1.04 (up from JP¥0.21 loss in 3Q 2023). Revenue: JP¥339.0m (up 12% from 3Q 2023). Net income: JP¥147.0m (up JP¥177.0m from 3Q 2023). Profit margin: 43% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings. Aankondiging • Dec 16
S Science Company, Ltd. to Report Q3, 2024 Results on Feb 13, 2024 S Science Company, Ltd. announced that they will report Q3, 2024 results on Feb 13, 2024 New Risk • Nov 16
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 38% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (38% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Market cap is less than US$100m (JP¥3.12b market cap, or US$20.6m). Reported Earnings • Nov 12
Second quarter 2024 earnings released: EPS: JP¥1.17 (vs JP¥0.064 loss in 2Q 2023) Second quarter 2024 results: EPS: JP¥1.17 (up from JP¥0.064 loss in 2Q 2023). Revenue: JP¥490.0m (up 54% from 2Q 2023). Net income: JP¥166.0m (up JP¥175.0m from 2Q 2023). Profit margin: 34% (up from net loss in 2Q 2023). Aankondiging • Sep 21
S Science Company, Ltd. to Report Q2, 2024 Results on Nov 10, 2023 S Science Company, Ltd. announced that they will report Q2, 2024 results on Nov 10, 2023 Reported Earnings • Aug 12
First quarter 2024 earnings released: EPS: JP¥1.50 (vs JP¥0.22 loss in 1Q 2023) First quarter 2024 results: EPS: JP¥1.50 (up from JP¥0.22 loss in 1Q 2023). Revenue: JP¥446.0m (up 31% from 1Q 2023). Net income: JP¥213.0m (up JP¥244.0m from 1Q 2023). Profit margin: 48% (up from net loss in 1Q 2023). Aankondiging • Jun 22
S Science Company, Ltd. to Report Q1, 2024 Results on Aug 10, 2023 S Science Company, Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023 Reported Earnings • May 16
Full year 2023 earnings released: JP¥0.74 loss per share (vs JP¥2.74 loss in FY 2022) Full year 2023 results: JP¥0.74 loss per share (improved from JP¥2.74 loss in FY 2022). Revenue: JP¥1.36b (up 18% from FY 2022). Net loss: JP¥105.0m (loss narrowed 68% from FY 2022). Aankondiging • May 14
S Science Company, Ltd., Annual General Meeting, Jun 29, 2023 S Science Company, Ltd., Annual General Meeting, Jun 29, 2023. Reported Earnings • Feb 15
Third quarter 2023 earnings released: JP¥0.21 loss per share (vs JP¥0.73 loss in 3Q 2022) Third quarter 2023 results: JP¥0.21 loss per share (improved from JP¥0.73 loss in 3Q 2022). Revenue: JP¥304.0m (up 1.3% from 3Q 2022). Net loss: JP¥30.0m (loss narrowed 68% from 3Q 2022). Aankondiging • Dec 27
S Science Company, Ltd. to Report Q3, 2023 Results on Feb 13, 2023 S Science Company, Ltd. announced that they will report Q3, 2023 results on Feb 13, 2023 Reported Earnings • Nov 16
Second quarter 2023 earnings released: JP¥0.064 loss per share (vs JP¥0.39 loss in 2Q 2022) Second quarter 2023 results: JP¥0.064 loss per share (improved from JP¥0.39 loss in 2Q 2022). Revenue: JP¥319.0m (up 28% from 2Q 2022). Net loss: JP¥9.00m (loss narrowed 79% from 2Q 2022). Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Outside Independent Director Seiji Arikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 13
Second quarter 2023 earnings released: JP¥0.064 loss per share (vs JP¥0.39 loss in 2Q 2022) Second quarter 2023 results: JP¥0.064 loss per share (improved from JP¥0.39 loss in 2Q 2022). Revenue: JP¥319.0m (up 28% from 2Q 2022). Net loss: JP¥9.00m (loss narrowed 79% from 2Q 2022). Aankondiging • Sep 17
S Science Company, Ltd. to Report Q2, 2023 Results on Nov 10, 2022 S Science Company, Ltd. announced that they will report Q2, 2023 results on Nov 10, 2022 Reported Earnings • Aug 12
First quarter 2023 earnings released: JP¥0.22 loss per share (vs JP¥0.77 loss in 1Q 2022) First quarter 2023 results: JP¥0.22 loss per share (up from JP¥0.77 loss in 1Q 2022). Revenue: JP¥340.0m (up 69% from 1Q 2022). Net loss: JP¥31.0m (loss narrowed 62% from 1Q 2022). Aankondiging • Jun 10
S Science Company, Ltd. to Report Q1, 2023 Results on Aug 10, 2022 S Science Company, Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022 Reported Earnings • May 16
Full year 2022 earnings released: JP¥2.74 loss per share (vs JP¥2.67 loss in FY 2021) Full year 2022 results: JP¥2.74 loss per share (down from JP¥2.67 loss in FY 2021). Revenue: JP¥1.16b (up 6.8% from FY 2021). Net loss: JP¥329.0m (loss widened 22% from FY 2021). Aankondiging • May 14
S Science Company, Ltd., Annual General Meeting, Jun 29, 2022 S Science Company, Ltd., Annual General Meeting, Jun 29, 2022. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Outside Independent Director Seiji Arikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Apr 08
S Science Company, Ltd. to Report Fiscal Year 2022 Results on May 12, 2022 S Science Company, Ltd. announced that they will report fiscal year 2022 results on May 12, 2022 Reported Earnings • Feb 10
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: JP¥0.73 loss per share (up from JP¥1.12 loss in 3Q 2021). Revenue: JP¥300.0m (up 26% from 3Q 2021). Net loss: JP¥93.0m (loss narrowed 18% from 3Q 2021). Revenue was in line with analyst estimates. Aankondiging • Nov 30
S Science Company, Ltd. announced that it has received ¥480 million in funding from LIH Co., Ltd. On November 29, 2021, S Science Company, Ltd closed the transaction. Reported Earnings • Nov 12
Second quarter 2022 earnings released: JP¥0.39 loss per share (vs JP¥1.12 loss in 2Q 2021) The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2022 results: Revenue: JP¥250.0m (up 5.0% from 2Q 2021). Net loss: JP¥43.0m (loss narrowed 62% from 2Q 2021). Aankondiging • Mar 13
S Science Company, Ltd. to Report Fiscal Year 2021 Results on May 14, 2021 S Science Company, Ltd. announced that they will report fiscal year 2021 results on May 14, 2021 Aankondiging • Mar 07
S Science Company, Ltd. announced that it expects to receive ¥2.75 million in funding from Evolution Capital Management, LLC S Science Co. Ltd. (TSE:5721) announced a third-party allotment agreement for a private placement of 250,000 units of the 6th Stock Acquisition Rights at an issue price of ¥11 per stock acquisition right for gross proceeds of ¥2,750,000 on March 5, 2021. The transaction will involve participation from Evo Fund, a fund managed by Evolution Capital Management, LLC. The stock acquisition right may be converted into 25,000,000 shares (100 shares per stock acquisition right), with initial exercise price of the amount equivalent to 90% of the condition determination standard stock price rounded up to the nearest ¥0.1., and no maximum exercise price. The company will raise ¥1,074,750,000 on exercise of security. The company will pay issuance expenses of ¥8,000,000 and will receive net proceeds on ¥1,074,750,000 on exercise of security. The period during which the stock acquisition rights can be exercised from March 30, 2021 to April 26, 2022. The allotment date is March 29, 2021. The transaction is approved by the board of directors of the company. Is New 90 Day High Low • Jan 12
New 90-day low: JP¥37.00 The company is down 20% from its price of JP¥46.00 on 14 October 2020. The Japanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 27% over the same period. Aankondiging • Dec 30
S Science Company, Ltd. to Report Q3, 2021 Results on Feb 12, 2021 S Science Company, Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021 Is New 90 Day High Low • Dec 22
New 90-day low: JP¥38.00 The company is down 17% from its price of JP¥46.00 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 16% over the same period. Is New 90 Day High Low • Dec 02
New 90-day low: JP¥43.00 The company is down 4.0% from its price of JP¥45.00 on 03 September 2020. The Japanese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 10.0% over the same period. Aankondiging • Aug 15
S Science Company, Ltd. (TSE:5721) completed the acquisition of Nagomi Sekkei Co., Ltd. from Yasuhiro Fukumura, Kyoko Fukumura, Wakabayashi Tetsuchun, Morita Shinada and others. S Science Company, Ltd. (TSE:5721) concluded a transfer agreement to acquire Nagomi Sekkei Co., Ltd. from Yasuhiro Fukumura, Kyoko Fukumura, Wakabayashi Tetsuchun, Morita Shinada and others for approximately ¥120 million on March 26, 2020. Post completion, Nagomi Sekkei will become wholly owned subsidiary of S Science Company. For the year ended March 31, 2019, Nagomi Sekkei had sales of ¥724 million, operating loss of ¥7 million, net loss of ¥1 million, net assets of ¥19 million and total assets of ¥193 million. Transaction was resolved by the Board of S Science Company. Transaction is expected to close on April 1, 2020.
S Science Company, Ltd. (TSE:5721) completed the acquisition of Nagomi Sekkei Co., Ltd. from Yasuhiro Fukumura, Kyoko Fukumura, Wakabayashi Tetsuchun, Morita Shinada and others on April 1, 2020.